Human Heart Mast Cells in Anaphylaxis and Cardiovascular Disease

1995 ◽  
Vol 107 (1-3) ◽  
pp. 72-75 ◽  
Author(s):  
Gianni Marone ◽  
Vincenzo Patella ◽  
Gennaro de Crescenzo ◽  
Arturo Genovese ◽  
Monika Adt
2019 ◽  
Vol 20 (14) ◽  
pp. 3395 ◽  
Author(s):  
Hermans ◽  
Lennep ◽  
van Daele ◽  
Bot

Mast cells are pluripotent leukocytes that reside in the mucosa and connective tissue. Recent studies show an increased prevalence of cardiovascular disease among patients with mastocytosis, which is a hematological disease that is characterized by the accumulation of mast cells due to clonal proliferation. This association suggests an important role for mast cells in cardiovascular disease. Indeed, the evidence establishing the contribution of mast cells to the development and progression of atherosclerosis is continually increasing. Mast cells may contribute to plaque formation by stimulating the formation of foam cells and causing a pro-inflammatory micro-environment. In addition, these cells are able to promote plaque instability by neo-vessel formation and also by inducing intraplaque hemorrhage. Furthermore, mast cells appear to stimulate the formation of fibrosis after a cardiac infarction. In this review, the available data on the role of mast cells in cardiovascular disease are summarized, containing both in vitro research and animal studies, followed by a discussion of human data on the association between cardiovascular morbidity and diseases in which mast cells are important: Kounis syndrome, mastocytosis and allergy.


Author(s):  
Vincenzo Patella ◽  
Arturo Genovese ◽  
Gianni Marone
Keyword(s):  

2000 ◽  
Vol 68 (10) ◽  
pp. 5517-5524 ◽  
Author(s):  
Arturo Genovese ◽  
Jean-Pierre Bouvet ◽  
Giovanni Florio ◽  
Bärbel Lamparter-Schummert ◽  
Lars Björck ◽  
...  

ABSTRACT Human heart mast cells (HHMC) have been identified in heart tissue, perivascularly, and in the intima of coronary arteries. In vitro activation of isolated HHMC induces the release of vasoactive and proinflammatory mediators (histamine, tryptase, and cysteinyl leukotriene C4 [LTC4]). We investigated the effects of several bacterial proteins on HHMC activation in vitro. HHMC released histamine, tryptase, and LTC4 in response toStaphylococcus aureus Cowan 1 and the immunoglobulin (Ig)-binding protein A, but not to S. aureus Wood 46, which does not synthesize protein A. The effect of protein A was inhibited by preincubation with monoclonal IgM VH3+. Some strains of Peptostreptococcus magnus express an Ig light chain-binding surface protein called protein L. Such bacteria and soluble protein L stimulated the release of preformed and newly synthesized mediators from HHMC. Preincubation of HHMC with either protein A or protein L resulted in complete cross-desensitization to a subsequent challenge with the heterologous stimulus or anti-IgE. Monoclonal IgE (κ chains) blocked protein L-induced release, whereas IgE (λ chains) had no effect. Streptococcal protein G, formyl-containing tripeptide, and pepstatin A did not activate HHMC. Bacterial products protein A and protein L and intact bacteria (S. aureus and P. magnus) activate HHMC by acting as Ig superantigens.


1995 ◽  
Vol 44 (S1) ◽  
pp. S22-S23 ◽  
Author(s):  
V. Patella ◽  
I. Marinò ◽  
B. Lamparter ◽  
A. Genovese ◽  
M. Adt ◽  
...  
Keyword(s):  

1997 ◽  
Vol 113 (1-3) ◽  
pp. 200-202 ◽  
Author(s):  
Vincenzo Patella ◽  
Gennaro de Crescenzo ◽  
Isabella Marinò ◽  
Arturo Genovese ◽  
Monika Adt ◽  
...  

1987 ◽  
Vol 20 (3-4) ◽  
pp. 288-290 ◽  
Author(s):  
K. Rydzyński ◽  
H. Dalen ◽  
T. Saetersdal ◽  
H. Engedal

Physiology ◽  
2015 ◽  
Vol 30 (5) ◽  
pp. 349-357 ◽  
Author(s):  
Terrie M. Williams ◽  
Penni Bengtson ◽  
Diana L. Steller ◽  
Donald A. Croll ◽  
Randall W. Davis

The incidence of cardiovascular disease in humans is more than three times that of many wild and domestic mammals despite nearly identical heart morphologies and responses to exercise. A survey of mammalian species from 0.002-kg shrews to 43,000-kg whales shows that the human heart is more dog-like than cat-like and that neither body size nor longevity accounts for the relative vulnerability to cardiovascular disease. Rather, a major difference is daily activity patterns, which may underlie the comparatively healthy hearts of wild mammals.


2017 ◽  
Vol 38 (suppl_1) ◽  
Author(s):  
M. Sandstedt ◽  
M. Jansson ◽  
K. Vukusic ◽  
M. Jonsson ◽  
A. Oldfors ◽  
...  

1995 ◽  
Vol 106 (4) ◽  
pp. 386-393 ◽  
Author(s):  
Vincenzo Patella ◽  
Gennaro de Crescenzo ◽  
Anna Ciccarelli ◽  
Isabella Marinò ◽  
Monika Adt ◽  
...  

2000 ◽  
pp. 455-477 ◽  
Author(s):  
Marone Gianni ◽  
Gennaro De Crescenzo ◽  
Vincenzo Patella ◽  
Francescopaolo Granata ◽  
Arturo Genovese ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document